Jupiter Neurosciences, Inc. Announces New Corporate Offices
Retrieved on:
Tuesday, September 21, 2021
MELAS, HQ, CNS, News, Harvard University, Degenerative disease, Clinical trial, MIT, Central nervous system disease, Inflammation, FDA, COVID-19, Peripheral nervous system, Disorder, Traffic barrier, Alzheimer's disease, Glycogen storage disease, Central nervous system, Board, Main Street, CEO, Company, Spinocerebellar ataxia, TBI, Plasma, IND, Oxidative stress, Friedreich's ataxia, Lists of diseases, Neuroscience, Pharmaceutical industry
Additionally, Jupiter has established an office at 127 Main Street, Boston, MA 02129.
Key Points:
- Additionally, Jupiter has established an office at 127 Main Street, Boston, MA 02129.
- "We expect to announce exciting additions to our management team as well, so stay tuned for more news."
- Jupiter Neurosciences has developed a unique and patented platform product, JOTROL, an enhancedresveratrol formulationthatdeliverssuperior oral bioavailability with a strong safety profile.
- Jupiter Neurosciences, Inc. is a clinical-stage pharmaceutical company focused on treating CNS disorders and rare diseases.